Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2012 45.91%
June 30, 2012 47.85%
March 31, 2012 31.54%
December 31, 2011 36.79%
September 30, 2011 40.82%
June 30, 2011 47.66%
March 31, 2011 25.91%
December 31, 2010 37.03%
September 30, 2010 43.43%
June 30, 2010 46.66%
March 31, 2010 46.07%
December 31, 2009 44.20%
September 30, 2009 36.06%
June 30, 2009 39.94%
March 31, 2009 40.34%
December 31, 2008 36.69%
September 30, 2008 35.50%
June 30, 2008 54.93%
March 31, 2008 43.39%
December 31, 2007 42.29%
September 30, 2007
June 30, 2007 35.76%
March 31, 2007 32.02%
December 31, 2006 31.32%
September 30, 2006 13.55%
Date Value
June 30, 2006 40.58%
March 31, 2006 40.37%
December 31, 2005 46.01%
September 30, 2005 21.67%
June 30, 2005 31.81%
March 31, 2005 19.88%
December 31, 2004 28.40%
September 30, 2004 12.59%
June 30, 2004 25.65%
March 31, 2004 39.88%
December 31, 2003 32.69%
September 30, 2003 44.77%
June 30, 2003 32.18%
March 31, 2003 30.68%
December 31, 2002 32.72%
September 30, 2002 16.62%
June 30, 2002 38.80%
March 31, 2002 28.89%
December 31, 2001 31.92%
September 30, 2001 12.40%
June 30, 2001 43.97%
March 31, 2001 31.79%
December 31, 2000 35.36%
September 30, 2000 20.38%
June 30, 2000 2.56%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 64.07%
Neogen Corp. 37.03%
QuidelOrtho Corp. 35.75%
Aspira Women's Health, Inc. 55.28%
VolitionRX Ltd. 28.37%